Carcinoid Tumor of the Middle Ear: A Report of Two Cases.

Q3 Medicine Tokai Journal of Experimental and Clinical Medicine Pub Date : 2025-04-20
Hikaru Yamamoto, Akihiro Sakai, Takanobu Teramura, Kyoko Odagiri, Go Ogura, Kazuhito Hatanaka, Takuma Tajiri, Naoya Nakamura, Masashi Hamada
{"title":"Carcinoid Tumor of the Middle Ear: A Report of Two Cases.","authors":"Hikaru Yamamoto, Akihiro Sakai, Takanobu Teramura, Kyoko Odagiri, Go Ogura, Kazuhito Hatanaka, Takuma Tajiri, Naoya Nakamura, Masashi Hamada","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Carcinoid tumors of the middle ear are rare and difficult to diagnose preoperatively. These low-grade malignant tumors require complete surgical removal; however, consensus on the amount of radicality required is lacking. Herein, we report two cases of carcinoid tumors of the middle ear.</p><p><strong>Case presentation: </strong>The first patient was a 40-year-old woman who presented with right-sided hearing loss and a white mass behind the tympanic membrane. The tumor was surgically removed using a transcanal approach, while maintaining an intact ossicular chain. The histopathological diagnosis was carcinoid tumor, and no additional treatment was administered. The second patient was a 28-year-old woman who presented with left-sided hearing loss and a white mass in the ear canal. Preoperative biopsy revealed a carcinoid tumor. The tumor was excised using the same approach as in Case 1 with tentative removal of the incus during surgery, and reconstruction with tympanoplasty type IIIc (Ost) was performed. No recurrence was observed in either case during > 3 years of follow-up.</p><p><strong>Conclusion: </strong>Treatment algorithms for carcinoid tumor of the middle ear are lacking; therefore, surgical plans vary according to the tumor extension. Furthermore, because carcinoid tumors are low-grade malignant tumors, long-term follow-up after complete macroscopic removal is necessary.</p>","PeriodicalId":38819,"journal":{"name":"Tokai Journal of Experimental and Clinical Medicine","volume":"50 1","pages":"14-20"},"PeriodicalIF":0.0000,"publicationDate":"2025-04-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Tokai Journal of Experimental and Clinical Medicine","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Carcinoid tumors of the middle ear are rare and difficult to diagnose preoperatively. These low-grade malignant tumors require complete surgical removal; however, consensus on the amount of radicality required is lacking. Herein, we report two cases of carcinoid tumors of the middle ear.

Case presentation: The first patient was a 40-year-old woman who presented with right-sided hearing loss and a white mass behind the tympanic membrane. The tumor was surgically removed using a transcanal approach, while maintaining an intact ossicular chain. The histopathological diagnosis was carcinoid tumor, and no additional treatment was administered. The second patient was a 28-year-old woman who presented with left-sided hearing loss and a white mass in the ear canal. Preoperative biopsy revealed a carcinoid tumor. The tumor was excised using the same approach as in Case 1 with tentative removal of the incus during surgery, and reconstruction with tympanoplasty type IIIc (Ost) was performed. No recurrence was observed in either case during > 3 years of follow-up.

Conclusion: Treatment algorithms for carcinoid tumor of the middle ear are lacking; therefore, surgical plans vary according to the tumor extension. Furthermore, because carcinoid tumors are low-grade malignant tumors, long-term follow-up after complete macroscopic removal is necessary.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
1.10
自引率
0.00%
发文量
32
期刊介绍: The Tokai Journal of Experimental and Clinical Medicine, also referred to as Tokai Journal, is an official quarterly publication of the Tokai Medical Association. Tokai Journal publishes original articles that deal with issues of clinical, experimental, socioeconomic, cultural and/or historical importance to medical science and related fields. Manuscripts may be submitted as full-length Original Articles or Brief Communications. Tokai Journal also publishes reviews and symposium proceedings. Articles accepted for publication in Tokai Journal cannot be reproduced elsewhere without written permission from the Tokai Medical Association. In addition, Tokai Journal will not be held responsible for the opinions of the authors expressed in the published articles.
期刊最新文献
Author Correction: Magnetic Resonance Imaging/Gadolinium-enhanced Vessel Wall Image after Bypass Surgery in Moyamoya Disease. A Case of Seborrheic Keratosis in an Adolescent: Quite Rare Disease in Japan. Carcinoid Tumor of the Middle Ear: A Report of Two Cases. Infective Endocarditis Caused by Methicillin-Resistant Staphylococcus epidermidis in the Infant of a Mother with Diabetes: A Case Report. Influence of Combination Therapy with Dulaglutide or Liraglutide and SGLT2 Inhibitors on Renal Outcomes in Patients with Type 2 Diabetes: A Post-hoc Analysis of the RECAP Study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1